[1] 中华心血管病杂志编委会.急性心肌梗塞溶栓疗法参考方案[J].中华心血管杂志(Chin Cardiovasc J),1996,24(5):328-9. [2] Ryan TJ,Antman EM,Brooks NH,et al. Update:ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)[J]. J Am Coll Cardiol,1999,34(3):890-911. [3] Fuster V,Badimon L,Badimon JJ,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes[J]. N Engl J Med,1992,336(4):242-50. [4] 刘东,唐斌,蒙善东,等.血液滤过在移植肾功能延迟恢复治疗中的应用[J].第一军医大学学报,2001,21(9):691-2.Liu D,Tang B,Meng SD,et al. Clinical study of hemofiltration in the treatment of delayed graft function[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2001,21(9):691-2. [5] 刘志强,王力,刘俊.国产与进口低分子肝素在血液透析中抗凝作用的比较[J].第一军医大学学报,2002,22(10):942-3.Liu ZQ,Wang L,Liu J.Comparison ofanticoagulation efficacy and clinical safety between imported and domestically manufaciured low-molecular-weight heparin during hemodialysis[J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002,22(10):942-3. [6] 邵燕,章成国,孙炽津,等.颅内静脉系统血栓形成的早期诊断及治疗[J].第一军医大学学报,2003,23(2):184-6.Shao Y,Zhang CG,Sun ZJ,et al. Early diagnosis and treatment of intracranial venous thrombosis[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003,23(2):1 84-6. [7] 高玉琪,李志樑,丁明学.等.急性前壁心肌梗死急性期ST段抬高形态与近期预后的关系[J].第一军医大学学报,2002,22(2):156-8.Gao YQ,Li ZL,Ding MX,et al. Relation of the ST-segment elevation pattern in acute phase of anterior wall acute myocardial infarction to short-term proguosis[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002.22(2):156-8. [8] 迟东升,刘伊丽,王鹏,等.超声心动图观察左室肥厚对评价高血压心肌微血管病变的价值[J].第一军医大学学报,2003,23(7):702-5.Chi DS,Liu YL,Wang P,et al. Value of echocardiography for observing left ventricular hypertrophy in the diagnosis of myocardial microvascular damage in hypertensives[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003,23(7):702-5. [9] Hirsh J,Levine MN. Low molecular weight heparin[J]. Blood,1992,79(1):1-17. [10] Fareed J,Hoppeusteadt DA. Pharmacology of low molecular weight heparins[J]. Semin Thromb Hemost,1996,22(Suppl 2):13-8. [11] Weitz JI. Low-molecular-heparins[J]. N Engl J Med,1997:337(10):688-98. [12] James JJ. Low molecular heparins and glycoprotein Ⅱ b/Ⅲ a antagonists[J]. J Interven Cardiol,2002,15(2):147-54. [13] Cohen M,Antman EM,Gurfmkel E,et al. Impact ofenoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction[J]. Am J Cardiol,2000,86(5):553-6. [14] Baird SH,Menown BA,Mcbride SJ,et al. Randomized comparison of enoxaparin with unfracfionated heparin following fibrinolytic therapy for acute myocardial infarction[J]. Eur Heart J,2002,23(8):627-32. |